Sopharma AD — Earnings Release 2025

Jan 20, 2026

{0}------------------------------------------------

Current report: № 20/2026 Dated: January 20, 2026

NOTIFICATION

Sofia, Bulgaria, January 20, 2026 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), "Sopharma" AD (SFA: "Bulgarian Stock Exchange" AD, SPH: Warsaw Stock Exchange) notifies, that for December 2025 the Company recorded increase in sales of 39% compared to the same month of the previous year, incl. 50% increase in domestic sales and 31% increase in export sales.

For 2025, the Company has achieved sales increase of 14%, including 5% increase in domestic sales and 20% increase in export sales.

Ognian Donev